Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management. (Q36478736)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700734%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

review article

1 reference

title

Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700734%20AND%20SRC:MED&resulttype=core&format=json

Herpes simplex virus type 1

21 January 2020

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700734%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Porter SR

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700734%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700734%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700734%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700734%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700734%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

254-270

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700734%20AND%20SRC:MED&resulttype=core&format=json

Famciclovir prophylaxis of herpes simplex virus reactivation after laser skin resurfacing

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Treatment of herpes simplex gingivostomatitis with aciclovir in children: a randomised double blind placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomised double blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

The Natural History of Recurrent Facial-Oral Infection with Herpes Simplex Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

A long-term prospective clinical study of orofacial herpes simplex virus infection in acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Acyclovir given as prophylaxis against oral ulcers in acute myeloid leukaemia: randomised, double blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

New therapeutic approaches to the alphaherpesvirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Molecular analysis of clinical isolates of acyclovir resistant herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Sun protection for children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Valaciclovir as a single dose during prodrome of herpes facialis: a pilot randomized double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Acyclovir-resistant, pathogenic herpesviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Chronic oral herpes simplex virus infection in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Recent advances in varicella-zoster virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Mechanism of action of foscarnet against viral polymerases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Herpes simplex and mood: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Acyclovir-resistant herpes simplex virus infections in a bone marrow transplant population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Synthesis and antiviral properties of 5-vinylpyrimidine nucleoside analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Herpes simplex virus resistant to acyclovir. A study in a tertiary care center

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Clinical study of herpes simplex virus infection in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

The many challenges of facial herpes simplex virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Recurrence and resistance patterns of herpes simplex virus following cessation of > or = 6 years of chronic suppression with acyclovir. Acyclovir Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Failure of topical acyclovir in ointment to penetrate human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Improving the outcome of facial resurfacing--prevention of herpes simplex virus type 1 reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

A comparative study of herpes simplex infections in renal transplant and leukemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Herpetic gingivostomatitis in otherwise healthy adolescents and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Treatment of mucocutaneous herpes simplex virus infections unresponsive to acyclovir with topical foscarnet cream in AIDS patients: a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Oral antivirals for the acute treatment of recurrent herpes labialis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Valacyclovir in the treatment of facial herpes simplex virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

A rapid and automated colorimetric assay for evaluating the sensitivity of herpes simplex strains to antiviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

A risk-benefit evaluation of aciclovir for the treatment and prophylaxis of herpes simplex virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Acyclovir-resistant, foscarnet-sensitive oral herpes simplex type 2 lesion in a patient with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Arthritis associated with recurrent erythema multiforme responding to oral acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

The incidence of oral herpes simplex virus infection in patients undergoing cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Herpes simplex virus resistance to antiviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Foscarnet therapy for acyclovir-resistant herpes simplex virus 1 infection in allogeneic bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Recent advances in the therapy and prevention of CMV infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

A simplified method for the detection of maedi-visna virus RNA by in situ hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Reactivation of oral herpes simplex virus: implications for clinical management of herpes simplex virus recurrence during radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Oral valacyclovir as prophylaxis against herpes simplex virus reactivation during high dose chemotherapy for leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

The anti-herpes simplex virus activity of n-docosanol includes inhibition of the viral entry process

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Use of acyclovir for prophylaxis of herpes infections in severely immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Acyclovir prophylaxis for oral herpes simplex virus infection in patients with bone marrow transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

The implications of drug resistance for strategies of combination antiviral chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Foscarnet-resistant herpes simplex virus infection in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation: analysis of factors associated with infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Detection of herpes simplex virus type 1 shedding in the oral cavity by polymerase chain reaction and enzyme-linked immunosorbent assay at the prodromal stage of recrudescent herpes labialis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Orofacial herpes simplex virus infections: current concepts in the epidemiology, pathogenesis, and treatment, and disorders in which the virus may be implicated

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Parenteral acyclovir therapy for herpesvirus infections in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Treatment of recurrent herpes simplex labialis with oral acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Th1/Th2-like immunity and resistance to herpes simplex labialis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Risk factors of herpes simplex type 1 (HSV-1) infection and lifestyle factors associated with HSV-1 manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Pharmacokinetics of acyclovir suspension in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Improved DNA hybridization method for detection of acyclovir-resistant herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Pharmacokinetics of oral acyclovir in neonates and in infants: a population analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Herpes simplex virus-associated erythema multiforme in prepubertal children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Herpes simplex virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Infections Caused by Herpes Simplex Virus in the Immunocompromised Host: Natural History And Topical Acyclovir Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Replication, latent infection, and reactivation in neuronal culture with a herpes simplex virus thymidine kinase-negative mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

Prolonged and potent therapeutic and prophylactic effects of (S)-1-[(3-hydroxy-2-phosphonylmethoxy)propyl]cytosine against herpes simplex virus type 2 infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2006.01202.X

10.1111/J.1601-0825.2006.01202.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700734%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference